CalciMedica, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 34.36 million compared to USD 7.82 million a year ago. Basic loss per share from continuing operations was USD 7.66 compared to USD 111.16 a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.2 USD | -7.14% | -5.80% | +81.81% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+81.81% | 59.61M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- CALC Stock
- News CalciMedica, Inc.
- CalciMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023